Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-DMA Protein (AA 27-233) (His tag)

HLA-DMA Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant Greater than 95 % as determined by SDS-PAGE ELISA, WB
N° du produit ABIN7123830
  • Antigène Voir toutes HLA-DMA Protéines
    HLA-DMA (Major Histocompatibility Complex, Class II, DM alpha (HLA-DMA))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 27-233
    Origine
    Humain
    Source
    • 2
    • 1
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette HLA-DMA protéine est marqué à la His tag.
    Application
    ELISA, Western Blotting (WB)
    Pureté
    Greater than 95 % as determined by SDS-PAGE
    Stérilité
    0.2 μm filtered
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    Buffer
    Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4
    Stock
    4 °C,-20 °C
    Stockage commentaire
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    Date de péremption
    12 months
  • Antigène
    HLA-DMA (Major Histocompatibility Complex, Class II, DM alpha (HLA-DMA))
    Autre désignation
    HLA-DMA (HLA-DMA Produits)
    Synonymes
    RT1.Ma Protein, RT1.DMa Protein, HLA-DMA Protein, H-2Ma Protein, H2-Ma Protein, D6S222E Protein, DMA Protein, HLADM Protein, RING6 Protein, RT1 class II, locus DMa Protein, SLA-DM alpha chain Protein, major histocompatibility complex, class II, DM alpha Protein, histocompatibility 2, class II, locus DMa Protein, RT1-DMa Protein, SLA-DMA Protein, DLA-DMA Protein, H2-DMa Protein, HLA-DMA Protein
    Poids moléculaire
    22.7 kDa
    UniProt
    Q6ICR9
    Pathways
    Cancer Immune Checkpoints
Vous êtes ici: